Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
Erythropoietin for acute multiple sclerosis in patients with optic neuritis as a first demyelination event.
The prospects of minocycline in multiple sclerosis.
Multiple sclerosis and sexual dysfunction.
Pediatric multiple sclerosis in Venezuela.
Multiple Sclerosis: Myeloperoxidase Immunoradiology Improves Detection of Acute and Chronic Disease in Experimental Model.
Wnt Signaling in the Pathogenesis of Multiple Sclerosis-Associated Chronic Pain.
Sativex(®) in multiple sclerosis spasticity: a cost-effectiveness model.
Effect of wearing a dorsiflexion assist orthosis on mobility, perceived fatigue and exertion during the six-minute walk test in people with multiple sclerosis: a randomised cross-over protocol.
Immune surveillance in multiple sclerosis patients treated with natalizumab.
A new prevalence study of multiple sclerosis in Orkney, Shetland and Aberdeen city.
Recommendations for the management of multiple sclerosis relapses.
Tapered withdrawal of phenytoin removes protective effect in EAE without inflammatory rebound and mortality.
Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis.
"Putting One Foot in Front of the Other": A Qualitative Study of Emotional Experiences and Help-Seeking in Women with Multiple Sclerosis.
Paroxysmal Hypothermia in Two Patients with Multiple Sclerosis.
A randomized trial of stress management for the prevention of new brain lesions in MS.
Distribution of JC polyomavirus genotypes in Tunisian renal transplant recipients between January 2008 and January 2011.
Importance of Rookshana Karma (dehydrating therapy) in the management of transverse myelitis.
MAIT cells in autoimmunity.
Effect of Fampridine-PR (prolonged released 4-aminopyridine) on the manual functions of patients with Multiple Sclerosis.
Major stressful life events in adulthood and risk of multiple sclerosis.
MS Treatment Is on the Cusp of Something Big: On the Cusp of Something Big?
Tangier's disease: An uncommon cause of facial weakness and non-length dependent demyelinating neuropathy.
T cell vaccination in multiple sclerosis: results of a preliminary study.
Pages
« first
‹ previous
…
142
143
144
145
146
147
148
149
150
…
next ›
last »